Kudos!
Congratulations to Research Awardees for fiscal year 2010
July-September
Federal Research Awardees by Department: |
||
| Principal Investigator | Project Title | Sponsor |
| Anatomy: | ||
| Dr. Paul May | Midbrain Circuitry for Neuronal Control of Gaze | National Eye Institute |
| Biochemistry: | ||
| Dr. Victor Davidson | Structure Function & Biosynthesis of Respiratory Enzymes | National Institute of General Medical Sciences |
| Dr. Michael Hebert | Nuclear bodies and ribonucleoprotein biogenesis - Recovery Act supplement | National Institute of General Medical Sciences |
| Dr. Drazen Raucher | Targeted Delivery of Therapeutic Peptides by Genetically Engineered Biopolymers | National Science Foundation |
| Dr. Donald Sittman | Mississippi Functional Genomics Network | University of Southern Mississippi/NIH |
| Cancer Institute: | ||
| Dr. Lucio Miele | PKC Alpha as a marker for Logical Therapeutic Approaches to Breast Cancer | University of Illinois at Chicago |
| Emergency Medicine: | ||
| Dr. Richard Summers | Digital Astronaut Project: Integrative Computer Model for the Analysis of Human Physiology in Microgravity | NASA - Johnson Space Center |
| Medicine: | ||
| Dr. Thomas Abell | Establishing UMMC's Clinical Center in NIDDK's Gastroparesis Research Consortium | National Institute of Diabetes, Digestive and Kidney Diseases |
| Dr. Luis Juncos | Suppressor ANGII Determines Acute & Chronic Renal Injury - Recovery Act Supplement | National Institute of Diabetes, Digestive and Kidney Diseases |
| Dr. Deborah Konkle-Parker | Multi-dimensional HIV Adherence Intervention | National Institute of Mental Health |
| Dr. Mario Sims | Disparities in CHD in the Jackson Heart Study | National Heart, Lung and Blood Institute |
| Dr. Herman Taylor | Diabetes and Insulin Resistance Effect on Echo LV Structure and Function-Minority Supplement | National Heart, Lung and Blood Institute |
| Dr. Herman Taylor | Jackson Heart Study - Examination Center | National Heart, Lung and Blood Institute |
| Microbiology: | ||
| Dr. Eva Bengten | The identification and characterization of virus specific cytotoxic cells in channel catfish | U.S. Department of Agriculture |
| Dr. Richard O'Callaghan | Staph Keratitis: Mechanism and Arrest of Ocular Damage | National Eye Institute |
| Dr. David Robinson | Horizontal Genetic Transfer in Staphylococi | National Institute of General Medical Sciences |
| Otolaryngology & Communicative Sciences: | ||
| Dr. Wu Zhou | Supplement (EQ) for Multiplicative Computation in the Vestibulo-Ocular Reflexes - Recovery Act Supplement | National Institute on Deafness and Other Communicatin Disorders |
| Pediatrics: | ||
| Dr. Rathi Iyer | Additional Centers for the Sickle Cell Disease Clinical Research Network | New England Research Institutes//NHLBI |
| Pharmacology & Toxicology: | ||
| Dr. George Booz | Regulation of IL-6 Type Cytokine Cardioprotective Signaling in the Ischemic Heart | National heart, Lung and Blood Institute |
| Dr. George Booz | Regulation of IL-6 Type Cytokine Cardioprotective Signaling in the Ischemic Heart - Recovery Act Supplement | National heart, Lung and Blood Institute |
| Dr. Roy Duhe | Pathophysiological Redox Regulation of JAK2 in Diabetes - Recovery Act funded | National Institute of Diabetes and Digestive and Kidney Diseases |
| Physiology & Biophysics: | ||
| Dr. Barbara Alexander | Research Infrastructure in Minority Institutions: Strengthening Biomedical Research | Tougaloo College/NIH |
| Dr. Robert Hester | Innovations through Computational Sciences-EPSCOR Proposal | Mississippi State University/NSF |
| Dr. Ruisheng Liu | Regulation of Superoxice Production at the Macula Densa During TGF | National Heart, Lung and Blood Institute |
| Dr. Ruisheng Liu | Regulation of Superoxide Production by the Macula Densa during TGF - Recovery Act Supplement | National Heart, Lung and Blood Institute |
| Dr. Christine Maric | Estrogen and Inflammation in Diabetic Nephropathy | National Institute of Diabetes, Digestive and Kidney Diseases |
| Dr. Michael Ryan | Blood Pressure, Renal Hemodynamics, and Inflammation Recovery Act Supplement | National Institute of Diabetes, Digestive and Kidney Diseases |
| Dr. David Stec | The Renal Medulla and Hypertension-Recovery Act supplement | National Heart, Lung and Blood Institute |
| Dr. David Stec | The Renal Medulla and Hypertension | National Heart, Lung and Blood Institute |
| Psychiatry & Human Behavior: | ||
| Dr. Scott Coffey | Affect Regulation Training Alcoholics | National Institute on Alcohol Abuse and Alcoholism |
| Dr. Kim Gratz | Developing an emotion regulation group therapy for self-harm among women with BPD | National Institute of Mental Health |
| Dr. Craig Stockmeier | Center for Research Excellence in Psychiatric Neuroscience | National Center for Research Resources |
| Dr. Grazyna Rajkowska | Cortical Cell Pathology in Depression | Duke University/NIMH |
| Dr. Julie Schumacher | Program of Excellence in Training and Dissemination of Motivational Interviewing | Natinal Institute on Drug Abuse |
| Dr. William L Woolverton | Self-administration of drug combinations: Polydrug abuse | National Institute on Drug Abuse |
****This is a list of research awardees for the first quarter of FY'2010. We apologize if any one's name has been inadvertently left out of this list. Please let us know and we will capture the information in the next issue of the Waves.****
Loan repayment Programs from NIH:
You do the research. NIH will repay your student loans. That is the idea behind the National Institutes of Health Loan Repayment Programs (LRPs).
THE FY 2010 APPLICATION CYCLE IS OPEN!
The Extramural New and Renewal Deadline is December 1, 2009 at 8 PM EST
NIH wants to encourage outstanding health professionals to pursue careers in biomedical, behavioral, social, and clinical research. If you commit at least two years to conducting qualified research funded by a domestic nonprofit organization or U.S. federal, state, or local government entity, NIH may repay up to $35,000 of your qualified student loan debt per year, including most undergraduate, graduate, and medical school loans. Loan repayment benefits are in addition to the institutional salary you receive for your research. Please visit http://www.lrp.nih.gov/ for more details about how to apply for this program.
National Science Foundation (Office of Integrative Activities (OIA) will solicit applications for the Major Research Instrumentation Program for the January 28, 2010 deadline.
Because the MRIP is a limited competition, this program requires UMMC to screen the applications and allow only the number permitted by the sponsor to be submitted for
funding consideration.
If you are interested in applying for the opportunity above, notify Pam Tazik ptazik@dor.umsmed.edu in the Office of Research by
Monday, November 2, 2009.
UMMC's limited submission competition guidelines are available at http://dor.umc.edu/RT/policies/Limited_Submission_ Competition_ GuidelinesFinal.pdf
The Bill & Melinda Gates Foundation is now accepting grant proposals for the Grand Challenges Explorations, a $100 million initiative to encourage bold and unconventional global health solutions.
Anyone can apply, regardless of your prior experience or institutional affiliation. Previous winners include graduate students, entrepreneurs at start-up companies, and creative thinkers from all fields of research. Proposals are currently being accepted online until November 2, 2009 on the following topics:
- Create New Ways to Protect Against Infectious Disease
- Create Low-Cost Diagnostics for Priority Global Health Conditions
- Create New Ways to Induce and Measure Mucosal Immunity
- Create New Technologies for Contraception
Click here to apply now.
Initial grants will be $100,000 each, and projects showing promise will have the opportunity to receive additional funding of up to $1 million. Full descriptions of topics and application instructions are available at: http://www.grandchallenges.org/explorations
UMMC American Cancer Society-Institutional Research Grant Program:
This is a final call for applications for individual ACS-IRG awards under the
UMMC-American Cancer Society Institutional Research Grant Program. These awards are typically up to $25,000 ($50,000 maximum for extraordinary applications) and are available to full-time faculty of the UMMC, as well as to faculty with joint UMMC/VA appointments, at the Instructor or Assistant Professor rank. Click here for eligibility requirements and details.
Applications are due to the Committee by Tuesday, December 1, 2009.
Applications must be routed through the UMMC Office of Research with an accompanying completed transmittal form, in accordance with the Policy on Routing and Approval of Intramural Research Proposals.
All compliance certifications must be verified before funds can be disbursed, and all funds must be disbursed before December 31, 2009. For further questions, please contact
Dr. Roy Duhe, Professor of Pharmacology and Toxicology at 601-984-1625 or email to rduhe@pharmacology.umsmed.edu
Recovery Act Limited Competition: Building Sustainable Community-Linked Infrastructure to Enable Health Science Research (RC4)
The NIH has established a new program entitled 'Building Sustainable Community-Linked Infrastructure to Enable Health Science Research', hereafter called the 'Community Infrastructure' grants program'. This NIH Funding Opportunity Announcement (FOA), supported by funds provided to the NIH under the American Recovery & Reinvestment Act of 2009, Public Law 111-5, solicits applications from domestic (United States) institutions/organizations proposing to support the development, expansion, or reconfiguration of infrastructures needed to facilitate collaboration between academic health centers and community-based organizations for health science research. Earliest application date is November 11, 2009 and applications are due by December 11, 2009.
The Recovery Act Limited Competition: Building Sustainable Community-Linked Infrastructure to Enable Health Sciece Research (RC4)
This NIH Funding Opportunity Announcement (FOA), supported by funds provided to the NIH under the American Recovery & Reinvestment Act of 2009, Public Law 111-5, solicits applications from domestic (United States) institutions/organizations proposing to support the development, expansion, or reconfiguration of infrastructures needed to facilitate collaboration between academic health centers and community-based organizations for health science research. Such collaboration should transform the way in which health science research is conducted in communities, and accelerate the pace, productivity, dissemination, and implementation of health research; applications that build upon extant collaborative infrastructures supported by other Federal agencies are strongly encouraged. Here is the link to the full announcement : http://grants.nih.gov/grants/guide/rfa-files/RFA-OD-09-010.html
Pre-filled parent application packages with institutional information for the R01, R03 and R21 mechanisms are available on our website now. You need to have a compatible version of Adobe Reader - 8.1.3 or higher to open these packages. If you need further assistance, please call the office of Research at 601-815-5000.
Reminder - Grant submission policy:
Final and complete grant application packages are due in the Office of Research
5 business days prior to the sponsor submission deadline. These packages must be accompanied by a completed transmittal form with the PI's and Chair/Dean's signatures. Packages that arrive with less than the 5 day turnaround, are incomplete, do not have final attachments, or do not have a transmittal form will be handled on a first come first served basis. More on submission policy details.
Biological safety Update :
Shipping Infectious Substances and Dry Ice:
It's the Law! Federal regulations require that all persons involved in the transportation of hazardous materials be trained. The purpose is to increase employees' safety awareness and be an essential element in reducing transportation incidents.
Department of Environmental Health and Safety provides Shipping Infectious Substance and Dry Ice training and encourages investigators to have a designated person from their lab to be properly trained. For more information, please contact Yolanda Griffin, Biological Safety Officer at 601-815-5074 or via email at vgriffin@hr.umsmed.edu.
Please visit the IBC website for guidelines and policies for activities involving bio-hazardous materials and/or Recombinant DNA. It is the primary responsibility of investigators to (1) Determine whether or not activities under their direction involve recombinant DNA or microbiological biohazards. (2) Classify the biohazard risk group and determine the biosafety level at which the activity should be conducted. (3) Register the activity with and seek approval from the UMC Institutional Biosafety Committee (IBC). (4) Comply with federal and institutional guidelines for safe handling of biohazard materials. (5) Inform personnel of risk potential and provide them with adequate training to minimize their exposure.
IACUC News:
Protocol Submission:
Beginning
January 1, 2010, investigators will be required to use the revised Animal
Activity Protocol Form (rev. 10/2009) that was recently approved by the IACUC
and now posted for use on the IACUC website: http://iacuc.umc.edu/iacucforms.html. The format of the Assurance/Search/Narrative
section has been changed to assist
investigators in providing the necessary information required by the USDA and
OLAW regulations. The Roland Medical
Library reference desk (ext. 4-1231) is available to provide additional
assistance with protocol searches, if needed.
IACUC Educational
Seminar:
Diversion
Investigator Angela Lee's October 14th PowerPoint presentation is
now available on-line and can be found on the IACUC website at http://iacuc.umc.edu/ -The 'nuts and bolts' on the DEA License Application
Process and 'Appropriate Disposal of Expired Controlled Substances'
Investigator
Lee advised that in the upcoming year, the Drug EnforcementAgency will resume inspection of Research
laboratories at the University of Mississippi Medical Center. If you are the holder of a DEA license, are
your records and security of drugs on hand in order? Investigators are encouraged to check out the
PowerPoint presentation, ask questions and take necessary action to be
compliant or maintain compliance with the DEA Regulations.
IACUCPolicy Review:
Management of Suspected Protocol Noncompliance
At the
request of the Research Compliance Subcommittee the IACUC has now provided examples of 'Animal Research Related Issues of
Noncompliance' with its policy now found on the IACUC website at the following link:
http://iacuc.umc.edu/documents/ManageSuspectedProtNoncompl_000.pdf
The IACUC
recognizes that over the life of an Animal Activity Protocol, the experimental
studies with animals may 'drift' or take seemingly minor departures from their original documented plan.These
deviations from the original, IACUC-approved protocol are considered issues of
noncompliance if they have not been previously covered by an amendment to the
original protocol.
All Principal Investigators and their staff
are requested to review and become familiar with the IACUC policy that governs
how instances of noncompliance are addressed by the IACUC. What may seem 'small' in the midst of a
procedure may have 'large' consequences after the fact, if not already approved in the
Animal Activity Protocol. If a study
action is happening to the live animal,
there should be a description of the action in the approved Animal
Activity Protocol or a subsequent amendment.
IRB Update:
IRB Policy Review: Management of Suspected Noncompliance
At the request of the Research Compliance Subcommittee, the IRB has created a 'fast fact' sheet with some examples of major violations of human research noncompliance. This information can be found in the Guidance section on the IRB website, http://irb.umc.edu/guidance.html
All Principal Investigators and their staff should review and become familiar with IRB policies, including those that explain how instances of suspected noncompliance are addressed. What may seem minor may have "large" consequences if it was not reviewed and approved by the IRB prior to implementation. More detailed information and all of the IRB policies and Procedures can be found at http://irb.umc.edu/newdoc/P&P_05-v3.2.pdf.
Reminder: IRB Review of Research Applications/Proposals:
UMMC is required to review all applications and proposals submitted for human subject research and to verify that the research described matches the corresponding protocol submitted to the IRB. A copy of the application or proposal should be submitted to the IRB as a part of the Initial Application, along with the protocol to be reviewed. The IRB will verify that the research described in the application or proposal is consistent with any corresponding protocol(s) submitted to the IRB and a copy of the application or proposal will be retained as a part of the IRB study file. No funds will be distributed until the verification has been made and the protocol has received IRB approval.
RePORTER - Research Portfolio Online Reporting Tool Expenditures and Results Tool - 
The NIH has released to the public a beta version of its new Research Portfolio Online Reporting Tool Expenditures and Results (RePORTER) tool.
http://projectreporter.nih.gov/reporter_SearchResults.cfm
You can get the listing of various awards by fiscal year, State and organization by leaving all other search fields as default all. These lists can also be downloaded to Excel.
RePORTER also provides links to PubMed Central, PubMed, and the US Patent & Trademark Office Patent Full Text and Image Database for more information on research results. New features will be added to RePORTER in several releases throughout fiscal year 2010.